glucose metabolism, a finding that might have implications for our understanding of human diabetes.
Blood-glucose regulation is essential for the body to function normally. In humans, this is achieved by a complex network of inter actions between several organs that is mediated by hormones and neuropeptide molecules. After a meal, glucose levels rise, and β-cells in the pancreas release the hormone insulin. Insulin binds to its receptor on the surface of liver, muscle and fat cells, stimulating them to take up glucose from the bloodstream, and thereby returning blood glucose levels to normal. Conversely, if blood glucose levels drop, for example between meals, pancreatic α-cells release the hormone glucagon, which stimulates the liver to break down its reserves of a glucose polymer called glycogen. The release of this glucose into the bloodstream once again returns blood glucose levels to normal.
Disturbance in these interplays can cause severe metabolic disorders, such as diabetes, which results in high blood-glucose levels and a range of deleterious effects. In type I diabetes, β-cells are destroyed by immune cells, and insulin is not produced. In type II diabetes, insulin is produced, but its levels are too low
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The healthy diabetic cavefish conundrum
Some Mexican cavefish have a mutation in an insulin receptor protein that affects blood-glucose regulation. The same mutation causes diabetes and health problems in humans, but the diabetic cavefish thrive. See Letter p.647
These and other T-cell populations in humans and mice, such as invariant natural killer T cells and germline-encoded mycolyl-reactive T cells, also act in response to MHC class Ib-mediated bacterial-peptide recognition 6, 7 . A human equivalent to mouse H2-M3 has not been identified so far. It is possible that, if such an equivalent is found, a human T-cell population might fulfil a similar role to that of the CD8 + T cells observed by Linehan and colleagues.
As the authors note, many of the day-to-day interactions between immune-system cells and microbes are probably with the commensals in the skin, gut and airways. Therefore, an immune response that maintains the status quo, rather than driving bacterial elimination, which is usually accompanied by inflammation and tissue damage, could be beneficial. But should such a response really be considered unconventional? Although the roles of classical MHC molecules and responding immune cells were identified first, non-classical MHC and MHC-like proteins are evolutionarily older 8, 9 than MHC class Ia molecules. Linehan and colleagues reveal a direct link between the role of MHC class Ib molecules and tissue homeostasis. Therefore, these functions might have evolved in parallel and represent the broadly 'conventional' functions of the immune system, with additional immune-system specializations evolving over time.
The authors' study hints at the potential broad, long-term effects of microbial residents on the immune system. If future studies mechanistically link individual microorganisms to specific types of immune response, it might be possible not only to understand the roles of some abundant and relatively unexplored immune-cell populations, but also to determine how resident microbes affect health and disease in a way that might lead to new treatment approaches. ■ 1 report an analysis of the killer-T-cell response to Staphylococcus epidermidis using mouse models and human cells. This type of bacterium, called a commensal, can become a long-term, non-pathogenic resident of the body. Killer T cells recognize S. epidermidis when an MHC class Ib molecule presents an antigen containing an N-formyl modification of an amino-acid residue. The T cell expresses genes associated with tissue repair, and the bacterium survives this 'unconventional' response. However, such immune responses are probably not neatly divided into these categories, and conventional T-cell responses might in some cases aid tissue repair and unconventional T-cell responses might aid host defence against pathogens.
Paul Klenerman and
or it is not recognized by the target tissues. This lack of an insulin response is known as insulin resistance.
Although studies of diabetes have focused mainly on mammalian systems, other creatures might offer a fresh perspective on the condition. Cavefish certainly look out of the ordinary, with their depigmented pink skin and eyeless faces (Fig. 1) . Hints that these fish have unusual metabolic adaptations for coping with their lightless and seemingly food-poor habitat led Riddle and colleagues to investigate them further. Cavefish have evolved behavioural and physiological traits that differ from those of the river-dwelling members of their species. Compared with river dwellers, cavefish are fatter, owing to a larger lipid reserve; they are better able to cope with starvation 2 ; have a lower oxygen consumption and metabolic rate 3 ; and the absence of circadian rhythms in their metabolism enables them to make a 27% saving in energy usage 4 . Riddle and colleagues now reveal another metabolic surprise. Cavefish have higher blood glucose levels than the river dwellers of the species. The authors' investigation revealed that cavefish are insulin resistant and have a mutant version of the insulin receptor, encoded by the insra gene, that does not bind and transduce the insulin signal. This mutation, in which the usual amino-acid residue proline is replaced by leucine, is identical to a change that causes diabetes and health problems in humans 5, 6 . To investigate the effect of this mutation in the fish, the authors used the CRISPRCas gene-editing technique to generate zebrafish (Danio rerio) carrying mutated insra. This experiment would perhaps have been even more informative if performed in a river-dwelling A. mexicanus, but the results are clear: if both the maternally and paternally inherited copy of insra have the mutation, the fish are insulin resistant and overweight. The insulin resistance makes sense, given what is known about this mutation in humans, but the weight gain is puzzling and unexpected, because insulin is a growth hormone. In humans and rodents, lack of a functional insulin receptor is associated with growth retardation and low body fat 7 . Does this mean that insulin signalling has divergent roles in fish and mammals? Zebrafish and A. mexicanus cavefish and river dwellers have two versions of the insulin receptor gene, called insra and insrb. This raises the question of why the receptor encoded by insrb doesn't compensate for the non-functional receptor encoded by the mutant version of insra. In zebrafish, the two receptors have overlapping roles in growth control and glucose metabolism through the action of the insulin signalling pathway, but they have opposing effects on lipid metabolism, and the receptor encoded by insra promotes lipid synthesis 8, 9 . However, in cavefish and in the gene-edited zebrafish, the insra gene is mutated, making this weight gain even more puzzling.
Perhaps one of the strangest findings is that cavefish have a respectable lifespan of more than 14 years, which is similar to that of the river-dwelling form. Moreover, they show fewer signs of age-related tissue decline. Elevated blood-glucose levels can damage tissue if the glucose bonds with proteins in a process termed glycation, which is linked to a range of health problems in people who have diabetes. However, cavefish do not have high levels of glycated proteins, so they must have evolved a compensatory mechanism. One way to unmask this mechanism might be to study cavefish in which gene editing is used to correct the insra gene mutation. The authors will undoubtedly be working on this, given the potential biomedical importance of identifying a glycation-inhibiting mechanism.
Further genetic analysis by the authors reveals the complexity of the mechanism that underlies the elevated-glucose phenomenon. The beauty of studying A. mexicanus is that the cavefish and river dwellers can interbreed. The authors therefore studied the patterns of inheritance of the elevated-glucose trait, and found that insra is not the only gene involved. In the offspring of interbreeding crosses, all of the fish that had high blood glucose had the cavefish insra mutation. However, some of the fish with this mutation did not have high blood glucose, indicating that the insra mutation is necessary but not sufficient to alter blood glucose regulation. The identification of other genes involved might shed light on the weight-gain phenomenon.
About 30 caves in Mexico are home to cavefish colonies 10 . Some of these populations arose from independent colonization events by river-dwelling ancestors. The authors compared three cavefish populations -two from the Tinaja and Pachón caves, which are in the same mountain range, and the third from the Molino cave in another mountain range. The authors found that all of these populations have high blood-glucose levels, but only those from Tinaja and Pachón have the insra mutation. Another mechanism must be at work in fish from Molino. The authors' analyses suggest that the insulin signalling pathway is unaffected in these fish, which also have high levels of glycated proteins. Molino cavefish have lived for more than 13 years in our lab oratory, suggesting that they also cope well with their unusual metabolism.
The convergent evolution of this extraordinary blood-glucose dysregulation, through different mechanisms in fish from different caves, seems counter-intuitive in terms of species fitness. What compensates for this surprising evolutionary path? The authors suggest that high fat reserves might help the fish to survive during extended periods of food deprivation.
However, perhaps something else is at play. Caves are probably not as food-poor as they seem. In the Tinaja cave (home of the main population investigated by Riddle and colleagues), the cavefish feed on mud that has a high carbon content 11 . Moreover, a substantial proportion of the fish in the Tinaja and Pachón populations have only one copy of the mutant version of insra. If a beneficial mutation has not spread throughout an entire population, one possible interpretation is that the mutation arose relatively recently in the population's history. This would imply that the early cave settlers did not have the benefit of being 1 report that cavefish from the Tinaja and Pachón caves in Mexico have high blood-glucose levels owing to a mutation in the insulin receptor protein that is identical to one that causes diabetes and a range of health problems in humans 5, 6 . Surprisingly, these cavefish are healthy and have a normal lifespan.
